Avalo Therapeutics

AVTX • NASDAQ • Stock Fundamentals

Avalo Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Garry A. Neil, with a market cap of $842.1M.

Market Cap$842.1M

Employees19.0

CEOGarry A. Neil

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Avalo Therapeutics

Avalo Therapeutics (AVTX) has a market capitalization of $842.1M and trades on NASDAQ.

Avalo Therapeutics has approximately 19 employees.